BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khanam A, Saleeb PG, Kottilil S. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells 2021;10:1097. [PMID: 34064375 DOI: 10.3390/cells10051097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hussein J, El-Bana MA, El-kHayat Z, El-Naggar ME, Farrag AR, Medhat D. Eicosapentaenoic acid loaded silica nanoemulsion attenuates hepatic inflammation through the enhancement of cell membrane components. Biol Proced Online 2022;24:11. [PMID: 36071378 DOI: 10.1186/s12575-022-00173-z] [Reference Citation Analysis]
2 Weiskirchen R. Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II”. Cells 2022;11:2403. [DOI: 10.3390/cells11152403] [Reference Citation Analysis]
3 Kim KR, Kim J, Back JH, Lee JE, Ahn DR. Cholesterol-Mediated Seeding of Protein Corona on DNA Nanostructures for Targeted Delivery of Oligonucleotide Therapeutics to Treat Liver Fibrosis. ACS Nano 2022. [PMID: 35500062 DOI: 10.1021/acsnano.1c08508] [Reference Citation Analysis]
4 Torres S, Segalés P, García-Ruiz C, Fernández-Checa JC. Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis. Cells 2022;11:1475. [PMID: 35563780 DOI: 10.3390/cells11091475] [Reference Citation Analysis]
5 Zahmatkesh E, Othman A, Braun B, Aspera R, Ruoß M, Piryaei A, Vosough M, Nüssler A. In vitro modeling of liver fibrosis in 3D microtissues using scalable micropatterning system. Arch Toxicol 2022. [PMID: 35366062 DOI: 10.1007/s00204-022-03265-7] [Reference Citation Analysis]
6 Tian Y, Cheng C, Wei Y, Yang F, Li G. The Role of Exosomes in Inflammatory Diseases and Tumor-Related Inflammation. Cells 2022;11:1005. [DOI: 10.3390/cells11061005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xin X, Xu H, Jian J, Lv W, Zhao Y, Li Y, Zhao X, Hu C. A method of three-dimensional branching geometry to differentiate the intrahepatic vascular type in early-stage liver fibrosis using X-ray phase-contrast CT. European Journal of Radiology 2022;148:110178. [DOI: 10.1016/j.ejrad.2022.110178] [Reference Citation Analysis]
8 Prins GH, Rios-Morales M, Gerding A, Reijngoud DJ, Olinga P, Bakker BM. The Effects of Butyrate on Induced Metabolic-Associated Fatty Liver Disease in Precision-Cut Liver Slices. Nutrients 2021;13:4203. [PMID: 34959755 DOI: 10.3390/nu13124203] [Reference Citation Analysis]
9 Lee SL, Hsu WH, Tu CM, Wang WH, Yang CY, Lee HK, Chin TY. The Effects of Freshwater Clam (Corbicula fluminea) Extract on Activated Hepatic Stellate Cells. Evid Based Complement Alternat Med 2021;2021:6065168. [PMID: 34804181 DOI: 10.1155/2021/6065168] [Reference Citation Analysis]
10 Sapudom J, ElGindi M, Arnoux M, Drou N, Garcia-Sabaté A, Teo JCM. Fibroblast Differentiation and Matrix Remodeling Impaired under Simulated Microgravity in 3D Cell Culture Model. Int J Mol Sci 2021;22:11911. [PMID: 34769342 DOI: 10.3390/ijms222111911] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Raj D, Sharma V, Upadhyaya A, Kumar N, Joshi R, Acharya V, Kumar D, Patial V. Swertia purpurascens Wall ethanolic extract mitigates hepatic fibrosis and restores hepatic hepcidin levels via inhibition of TGFβ/SMAD/NFκB signaling in rats. J Ethnopharmacol 2021;284:114741. [PMID: 34699946 DOI: 10.1016/j.jep.2021.114741] [Reference Citation Analysis]
12 Ezhilararasan D, Lakshmi T, Raut B, S VK. Novel Nano-Based Drug Delivery Systems Targeting Hepatic Stellate Cells in the Fibrotic Liver. Journal of Nanomaterials 2021;2021:1-9. [DOI: 10.1155/2021/4674046] [Reference Citation Analysis]
13 Khanam A, Chua JV, Kottilil S. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. Int J Mol Sci 2021;22:5497. [PMID: 34071064 DOI: 10.3390/ijms22115497] [Reference Citation Analysis]